Search results for "ffpe challenges"
Results per page
10000 Results Found | Selected Filters:
How single-cell metabolomics and AI could transform toxicity prediction and drug discovery
DeepCyte CEO Theodore Alexandrov explains how metabolomics and AI are advancing predictive toxicology, drug safety, and digital cell models
Join ZEISS at AACR 2015
LECO Honored with Pittcon Award
General V3 Western Blotting Protocol
VRNxT technology for increased precision and accuracy in rare cell workflows
The automated volume reduction instrument from Menarini Silicon Biosystems was debuted at 25th annual meeting of the Association for Molecular Pathology
Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
SCIEX Launches the CESI 8000 Plus, a High Performance CESI-MS Platform that Delivers High Resolution and Ionization Efficiency
The next generation CESI-MS system extends capabilities for biopharmaceutical, proteomics and metabolomics researchers
Oxford Gene Technology Expands Next Generation Sequencing Portfolio
New NGS products for streamlined sample prep and ovarian cancer research
icon16™
n6 Tec., IncThe icon16™ brings AutoNorm™ adaptive amplification to lower-throughput NGS workflows, with up to 16 samples at a time. Designed for labs that refuse to compromise on data quality, it delivers per-well real-time fluorescence monitoring and automatic library normalization in a compact, benchtop footprint.
Analysis of PFAS compounds in drinking water and soil to meet regulatory guidelines
Watch this on-demand webinar to find out all you need to know for meeting lab validation and performance requirements
Monitor Multiple Instruments in Real-Time with DxONE™ Clinical Information Management Tools
This informatics portfolio provides integrated solutions empowering operational and clinical decision-making
LightSwitch™ miRNA Target Validation Services
Active MotifFull screening service to validate the 3´UTR targets of specific miRNAs

















